<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01793324</url>
  </required_header>
  <id_info>
    <org_study_id>D1443C00128</org_study_id>
    <nct_id>NCT01793324</nct_id>
  </id_info>
  <brief_title>EMR Data to Assess Monitoring of Patients Treated With Quetiapine</brief_title>
  <official_title>Objective Assessment of Metabolic Monitoring in Patients Treated With Seroquel® or Seroquel® XR/Quetiapine Fumarate: Use of IMS Disease Analyzer to Assess Physician Behaviour in the UK and Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to evaluate the effectiveness of an update of educational materials with respect to
      evaluation of monitoring of metabolic parameters
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective assessment of metabolic monitoring in patients treated with Seroquel® or Seroquel®
      XR/quetiapine fumarate: use of IMS Disease Analyzer to assess physician behaviour in the UK
      and Germany
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination whether physicians in the UK and Germany perform monitoring of patients treated with Seroquel® and Seroquel® XR including measurement of the following during patient encounters: weight at drug initiation and over the course of treatment.</measure>
    <time_frame>Over 6 months following the distribution of metabolic educational materials in the country</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Monitoring of hyperlipidemia during patient encounters.</measure>
    <time_frame>Over 6 months following the distribution of metabolic educational materials in the country</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Monitoring for signs and symptoms of hyperglycemia during patient encounters.</measure>
    <time_frame>Over 6 months following the distribution of metabolic educational materials in the country</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Monitoring of blood glucose in patients with diabetes; monitoring of patients with risk factors for diabetes for worsening of glycemic control during patient encounters.</measure>
    <time_frame>Over 6 months following the distribution of metabolic educational materials in the country</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Counseling patients on healthy eating, exercise and healthy lifestyle improvements during patient encounters.</measure>
    <time_frame>Over 6 months following the distribution of metabolic educational materials in the country</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">6153</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Bipolar Disorder</condition>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>GER</arm_group_label>
    <description>All patients with a diagnosis of schizophrenia, bipolar disorder or major depressive disorder treated with Seroquel® or Seroquel® XR seen by general practitioners and psychiatrists in Germany based upon patient encounters recorded in IMS Disease Analyzer during the calendar period 13 February 2012 - 31 August 2012</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UK</arm_group_label>
    <description>All patients with a diagnosis of schizophrenia, bipolar disorder or major depressive disorder treated with Seroquel® or Seroquel® XR seen by general practitioners in the United Kingdom based upon patient encounters recorded in IMS Disease Analyzer during the calendar period from 11 January 2012 - 31 July 2012</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cross sectional assessment of physician encounters with patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Electronic medical records of patients with diagnoses of schizophrenia, Bipolar Disorder
        (BPD) or Major Depressive Disorder (MDD) treated with Seroquel® or Seroquel®XR during the
        calendar periods: 13 Feb - 31 Aug 2012 seen by GP &amp; psychiatrists in Germany &amp; 11 Jan-31
        July 2012 seen by GPs in the UK

        Exclusion Criteria:

        - Patients with above mentioned diagnoses treated with Seroquel® or Seroquel® XR/quetiapine
        fumarate not having any medical encounters during the time periods: 13 Feb - 31 Aug 2012 in
        Germany &amp; 11 Jan-31 July 2012 by GPs in the UK
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S Brody, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>AZ</affiliation>
  </overall_official>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2013</study_first_submitted>
  <study_first_submitted_qc>February 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>January 27, 2014</last_update_submitted>
  <last_update_submitted_qc>January 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Effectiveness of risk minimization</keyword>
  <keyword>Metabolic monitoring</keyword>
  <keyword>Seroquel® or Seroquel® XR/quetiapine fumarate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quetiapine Fumarate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

